发明名称 |
CELL-BOUND COMPLEMENT ACTIVATION PRODUCTS AS DIAGNOSTIC BIOMARKERS FOR PRE-LUPUS |
摘要 |
Cell-bound complement activation product (CB-CAP) profiling and scoring serve as diagnostic biomarkers for patients to determine whether a patient who has not met at least four American College of Rheumatology (or similar e.g. SLICC) criteria for a definite Lupus diagnosis should be classified as exhibiting a pre-existing condition that this document refers to as pre-Lupus. |
申请公布号 |
EP2954071(A4) |
申请公布日期 |
2016.09.28 |
申请号 |
EP20140749149 |
申请日期 |
2014.02.06 |
申请人 |
ALLEGHENY-SINGER RESEARCH INSTITUTE |
发明人 |
AHEARN, JOSEPH, M.;LIU, CHAU-CHING;MANZI, SUSAN, M. |
分类号 |
C12Q1/68;G01N33/49;G06F19/10 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|